Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Validation of a Stability-Indicating RP-LC Method for the Determination of Tigecycline in Lyophilized Powder

Texto completo
Autor(es):
da Silva, Lucelia Magalhaes [1] ; Nunes Salgado, Herida Regina [1]
Número total de Autores: 2
Afiliação do(s) autor(es):
[1] UNESP, Fac Pharmaceut Sci Araraquara, Postgrad Program Pharmaceut Sci, Araraquara, SP - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: Journal of Chromatographic Science; v. 51, n. 2, p. 192-199, FEB 2013.
Citações Web of Science: 4
Resumo

A reversed-phase liquid chromatography (RP-LC) method was validated for the determination of tigecycline in lyophilized powder. The LC method was conducted on a Luna C18 column (250 x 4.6 mm i.d.), maintained at room temperature. The mobile phase consisted of buffer containing sodium phosphate monobasic (0.015M) and oxalic acid (0.015M) (pH 7.0) acetonitrile (75:25, v/v), run at a flow rate of 1.0 mL/min and using. ultraviolet detection at 280 nm. The chromatographic separation was obtained with a retention time of 8.6 min, and was linear in the range of 40-100 mu g/mL (r(2) = 0.9997). The specificity and stability-indicating capability of the method was proven through forced degradation studies, which also showed no interference of the excipients. The accuracy was 99.01% with a bias lower than 1.81%. The limits of detection and quantitation were 1.67 and 5.05 mu g/mL, respectively. Moreover, method validation demonstrated satisfactory results for precision and robustness. The proposed method was applied for the analysis of the lyophilized powder formulation, contributing to improve the quality control and to assure the therapeutic efficacy. (AU)

Processo FAPESP: 09/53434-2 - Desenvolvimento e validação de metodologia analítica e estudo de estabilidade de tigeciclina em produto farmacêutico
Beneficiário:Lucelia Magalhaes da Silva
Modalidade de apoio: Bolsas no Brasil - Doutorado